Washburn, R.L.; Mueller, K.; Kaur, G.; Moreno, T.; Moustaid-Moussa, N.; Ramalingam, L.; Dufour, J.M.
C-Peptide as a Therapy for Type 1 Diabetes Mellitus. Biomedicines 2021, 9, 270.
https://doi.org/10.3390/biomedicines9030270
AMA Style
Washburn RL, Mueller K, Kaur G, Moreno T, Moustaid-Moussa N, Ramalingam L, Dufour JM.
C-Peptide as a Therapy for Type 1 Diabetes Mellitus. Biomedicines. 2021; 9(3):270.
https://doi.org/10.3390/biomedicines9030270
Chicago/Turabian Style
Washburn, Rachel L., Karl Mueller, Gurvinder Kaur, Tanir Moreno, Naima Moustaid-Moussa, Latha Ramalingam, and Jannette M. Dufour.
2021. "C-Peptide as a Therapy for Type 1 Diabetes Mellitus" Biomedicines 9, no. 3: 270.
https://doi.org/10.3390/biomedicines9030270
APA Style
Washburn, R. L., Mueller, K., Kaur, G., Moreno, T., Moustaid-Moussa, N., Ramalingam, L., & Dufour, J. M.
(2021). C-Peptide as a Therapy for Type 1 Diabetes Mellitus. Biomedicines, 9(3), 270.
https://doi.org/10.3390/biomedicines9030270